Le Lézard
Classified in: Health, Science and technology
Subject: FDA

Esco Medical secures CFDA approval on the MIRI(R) TL and MIRI(R) Embryo Incubators


SINGAPORE, Nov. 13, 2018 /PRNewswire/ -- Esco Medical, the IVF medical technology business unit of the Esco Group, today announced that it has received the China Food and Drug Administration (CFDA) approval on the MIRIŽ Time-Lapse and MIRIŽ Benchtop Multi-room embryo incubators.

The MIRIŽ TL is a time-lapse incubator with a built-in camera that captures continuous images during the embryo's development without disturbing it in any way. Combined with a specially designed propriety software (MIRIŽ TL Viewer), the system enables detailed scoring of embryos by the embryologists, thus providing valuable information for improved embryo selection process and patient communication. The MIRIŽ is a benchtop multi-room Incubator that allows embryologists to access their embryo cultures, without affecting the neighbouring chambers. The 6-chamber format prevents cross-contamination, while the highly efficient and specialized filters continuously scrub the air flowing through the system to ensure no airborne contaminants enter.

The fundamental design concept behind MIRIŽ and MIRIŽ TL improves upon the Silent Embryo Hypothesis by minimizing stressful factors that may be introduced when taking the dishes out of the incubator. Both incubators have excellent recovery rates, unique and stable incubation environments (including built-in pH monitoring), and excellent quality-control features.

"We are very proud to add The MIRIŽ and MIRIŽ TL to the list of CFDA approved products, thanks to the extensive quality control features built into their design. Time-Lapse is a very promising technology in the field of assisted reproduction, and we look forward to serving our current and future customers, as well as enabling IVF clinics to benefit from observing the dynamics of embryo development" says XiangQian (XQ) Lin, Group President and CEO.

About Esco

Founded in 1978, the Esco Group of companies is a Singapore based enterprise, developing and providing high-quality life science equipment and services globally. The group has a sales footprint in over 100 countries and a team of over 1,000 highly qualified professionals worldwide. In addition to innovating and manufacturing equipment for the pharma lab and assisted reproduction industries, Esco group also has a venture arm specializing in biotechnology, a testament to the fact that we are living in the century of biotechnology.

Esco Medical, the IVF equipment manufacturing division of the company, continues to help the world's leading IVF centres improve success rates and patient satisfaction.

Esco Group, building bridges to the world.


These press releases may also interest you

at 18:50
Getting specialty medications into...

at 18:30
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

at 18:23
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

at 17:55
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...



News published on and distributed by: